INVITAE CORP. news, videos and press releases
For more news please use our advanced search feature.
INVITAE CORP. - More news...
INVITAE CORP. - More news...
- Labcorp Finalizes Acquisition of Select Assets of Invitae
- Invitae Launches Unlock™ Behind the Seizure® Program for Pediatric Epilepsy Patients
- New Research Demonstrates the Importance of Genetic Testing for Many Cancers Not Currently Covered by Clinical Guidelines
- Invitae Receives Court Approval for Sale to Labcorp
- Labcorp Announces Winning Bid for Select Assets of Invitae
- Invitae Enters into Agreement with Labcorp for Sale of Business
- Invitae Publishes its Environmental, Social and Governance (ESG) Report
- Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance
- Invitae Launches Update to Invitae Generation™: Clinical Variant Modeling Improves Variant Classification
- Invitae Reports Estimated Unaudited Fourth Quarter and Full Year 2023 Financial Results
- Invitae to Present Data at the 2024 ACMG Annual Clinical Genetics Meeting
- Invitae Files for Voluntary Chapter 11 Protection; Pursues Sale Process
- Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease Therapeutics
- Invitae Completes Sale of Reproductive Health Assets to Natera
- Invitae Divests Ciitizen Health Data Platform and Implements Further Cost Cuts
- Invitae Reports Third Quarter 2023 Financial Results
- Invitae Launches Enhanced Chemistry of MRD Test to Better Serve Biopharmaceutical Clinical and Research Partnerships
- Invitae to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023
- Landmark Study Reveals Magnitude of Uncertain Results in Clinical Genetic Testing for Hereditary Disease, Points to Evidence-Based Solutions to Reach Definitive Results
- Invitae Appoints Dr. David Sholehvar as Chief Operating Officer
- Rural Hospital System Demonstrates the Clinical Benefits of Implementing Universal Hereditary Cancer Testing in Patients with Breast Cancer
- Invitae to Present Data at the National Society of Genetic Counselors 42nd Annual Conference That Supports Advancements in Medical Genomics
- Invitae's Common Hereditary Cancers Panel Receives FDA Market Authorization
- Invitae Announces Appointment of Finance Veteran Ana Schrank as CFO
- Invitae Receives Notice of Non-Compliance with NYSE Minimum Share Price Continued Listing Standard
- Invitae Hires Industry Veteran Robert Guigley as Chief Commercial Officer
- Clinical Trial Results Support Genetic Testing of All Patients with Prostate Cancer
- Invitae Announces Selection of Finance Executive Robert Dickey as Interim CFO
- Invitae Reports Second Quarter 2023 Financial Results
- Invitae to Announce Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
